product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
AKT Serine/Threonine Kinase 1 Peptide 2
catalog :
CPTC-AKT1-1
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CPTC-AKT1-1
reactivity :
human
more info or order :
product information
Internal ID :
30011
Name :
CPTC-AKT1-1
Depositor Name :
Clinical Proteomics Technologies for Cancer
Depositor Institution :
National Cancer Institute
Depositor Website :
http://proteomics.cancer.gov
Date Deposited :
5/10/17
Allow Hybridoma Distribution :
No
Cells Available (legacy) :
No
Antigen :
AKT Serine/Threonine Kinase 1 Peptide 2
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG2b, kappa light chain
Positive Tested Species Reactivity :
Human
Depositor Notes (Special Instructions) :
This antigen is also known as RAC-alpha serine/threonine-protein kinase. This antibody has been validated by Immuno-MRM against the synthetic peptide.
Collections :
Cancer targets - NCI,Enzymes,Human
Search Keywords :
Clinical Proteomics Technologies for Cancer, AKT Serine/Threonine Kinase 1 Peptide 2, Human, MIgG2b, kappa light chain, Human, AKT1, AKT, PKB, PRKBA, RAC, , Monoclonal, Human/nci - cancer targets/enzymes,
Antigen Molecular Weight :
55.6 kDa
Gene :
AKT1
Alternate Gene Name(s) :
AKT, PKB, PRKBA, RAC
Uniprot ID :
P31749
Antibody Registry ID :
AB_2722012
Immunogen :
Synthetic peptide
Immunogen Sequence :
SLLSGLLK (a.a. 378-385)
Clonality :
Monoclonal
Myeloma Strain :
P3x63Ag8.653
Epitope Mapped :
Yes
Additional Information :
RRID:AB_2722012
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
- AKT Serine/Threonine Kinase 1 Peptide 1 | CPTC-AKT1-2
- AKT Serine/Threonine Kinase 1 Peptide 2 | CPTC-AKT1-3
- V-Akt Murine Thymoma Viral Oncogene Homolog 2 Peptide 3 | CPTC-AKT2-1
- V-Akt Murine Thymoma Viral Oncogene Homolog 2 Peptide 3 | CPTC-AKT2-2
- V-Akt Murine Thymoma Viral Oncogene Homolog 2 Peptide 4 | CPTC-AKT2-3
questions and comments